ELIXIRGEN
LIVE

Serial Number

87190457

Owner

Elixirgen, LLC

Attorney

Leonard D. Bowersox

First Use Date

May 19, 2016

Filing Date

Oct 1, 2016

Add to watchlist:

No watchlists yet
View on USPTO

ELIXIRGEN Trademark

Serial Number: 87190457 • Registration: 5320821

ELIXIRGEN is a trademark filed by Elixirgen, LLC on October 1, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Elixirgen, LLC (4 trademarks)

855 N. Wolfe Street, Suite 621
Baltimore, MD 21205

Entity Type: 16

Trademark Details

Filing Date

October 1, 2016

Registration Date

October 31, 2017

First Use Anywhere

May 19, 2016

First Use in Commerce

May 19, 2016

Published for Opposition

August 15, 2017

Goods & Services

Development of pharmaceutical products for others; product quality testing and evaluation for others; research and development of pharmaceutical products for others; research and development of medical products for others

pharmaceutical preparations and substances for the treatment of telomere-shortening diseases (e.g., dyskeratosis congenita, Fanconi anemia, idiopathic and pulmonary fibrosis), karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, cancer; chemicals and chemical preparations for medical and pharmaceutical purposes for telomere-shortening diseases (e.g., dyskeratosis congenita, and Fanconi anemia), idiopathic pulmonary fibrosis, karyotype abnormalities (e.g., Down syndrome, and Edwards Syndrome), motor neuron diseases (e.g., Amyotrophic lateral sclerosis, multifocal neuropathy, primary lateral sclerosis, progressive muscular atrophy, progressive bulbar palsy, and pseudobulbar palsy), muscular diseases (e.g., Muscular atrophies, muscular growth, myopathy diseases, muscular disorders, muscular dystrophy, myositis, neuromuscular diseases, and sarcopenia), diseases related to the brain, diseases related to the spine, and cancers

Filing History

TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 30, 2026 PARI
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Sep 27, 2023 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Sep 27, 2023 8.OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Sep 26, 2023 EROP
POST REGISTRATION ACTION MAILED - SEC. 8
Aug 23, 2023 PRA8
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 22, 2023 APRE
TEAS SECTION 8 RECEIVED
Mar 21, 2023 ES8R
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 17, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2023 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 17, 2023 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Oct 31, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 12, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 11, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2017 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 10, 2017 TCCA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 17, 2017 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Jan 17, 2017 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Jan 17, 2017 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Jan 17, 2017 CPEA
ASSIGNED TO EXAMINER
Jan 10, 2017 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 7, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 6, 2016 NWOS
NEW APPLICATION ENTERED
Oct 5, 2016 NWAP